Journal of Neurology, Neurosurgery and Psychiatry
is a leading international journal publishing the latest research and reviews on all areas of neurological sciences.
Impact Factor: 13.654
Citescore:15.1
All metrics >>
Authors
JNNP accepts submissions of a wide range of article types, including review articles and original research.
The Author Information section provides specific article requirements to help you turn your research into an article suitable for JNNP.
Information is also provided on editorial policies and open access.
Latest Articles
Neurodegeneration:
Plasma phosphorylated tau 181 predicts amyloid status and conversion to dementia stage dependent on renal function15 May 2023
Neurodegeneration:
Plasma biomarkers for Alzheimers disease: a field-test in a memory clinic15 May 2023
Neurodegeneration:
Elevated plasma p-tau181 levels unrelated to Alzheimers disease pathology in amyotrophic lateral sclerosis15 May 2023
Most Read Articles
Editor's Choice
Neurodegeneration:
Elevated plasma p-tau181 levels unrelated to Alzheimer’s disease pathology in amyotrophic lateral sclerosis15 May 2023
Cognition:
CSF ferritin in the clinicopathological progression of Alzheimer’s disease and associations with APOE and inflammation biomarkers14 February 2023
Cerebrovascular disease:
Circadian rhythm of ischaemic core progression in human stroke14 December 2022
COVID-19
PostScript:
Humoral and cellular responses to SARS-CoV-2 vaccination in patients with autoantibody-mediated neuroimmunology15 May 2023
Multiple sclerosis:
Low protection from breakthrough SARS-CoV-2 infection and mild disease course in ocrelizumab-treated patients with multiple sclerosis after three mRNA vaccine doses25 April 2023
Altmetrics
Podcasts
Featured Video
Cognitive and neuropsychiatric effects of noradrenergic treatment in Alzheimer’s disease
Repurposing of established noradrenergic drugs is most likely to offer effective treatment in Alzheimer’s disease for general cognition and apathy. However, several factors should be considered before designing future clinical trials. These include targeting of appropriate patient subgroups and understanding the dose effects of individual drugs and their interactions with other treatments to minimise risks and maximise therapeutic effects.
Find out more